Results 171 to 180 of about 71,850 (241)

Coronary Artery Stenosis Following Aortic Valve Replacement and Intermittent Intracoronary Cardioplegia

, 1982
D. Glenn Pennington, Bulent Dincer, Hind M. Bashiti, Hendrick B. Barner, George C. Kaiser, Denis H. Tyras, John E. Codd, Vallee L. Willman   +7 more
openalex   +1 more source

LONG TERM OUTCOMES OF TRANSCATHETER AORTIC VALVE REPLACEMENT IN VERY LOW-GRADIENT LOW-FLOW AORTIC STENOSIS BASED ON LEFT VENTRICULAR EJECTION FRACTION

, 2023
Hiroki Ueyama, Lakshay Chopra, Francesca Romana Prandi, Malcolm Anastasius, Gilbert H.L. Tang, Samin K. Sharma, Annapoorna Kini, Stamatios Lerakis   +7 more
openalex   +1 more source

Severe Supravalvular Aortic Stenosis Treated With Double Patch Aortoplasty: A Case Report

Clinical Case Reports, Volume 14, Issue 2, February 2026.
ABSTRACT Severe supravalvular aortic stenosis in a young patient is a rare but critical condition requiring timely diagnosis and intervention. We report a 15‐year‐old girl presenting with exertional dyspnea, chest pain, and palpitations. Echocardiography and multidetector computed tomography (MDCT) confirmed severe supravalvular aortic stenosis ...
Birat Kadel, Ashok Paudel, Parbej Allam, Sumin Thapa, Sujan Dhital   +4 more
wiley   +1 more source

Hemodynamic Alteration in Aortic Valve Stenosis: CFD Insights from Leaflet-Resolved Models. [PDF]

Bioengineering (Basel)
Nuhash MM, Lai VK, Zhang R.
europepmc   +1 more source

Heyde Syndrome: A Literature Review

Health Science Reports, Volume 9, Issue 2, February 2026.
ABSTRACT Background and Aims Heyde syndrome, a triad of anemia from gastrointestinal (GI) bleeding, aortic valve stenosis, and acquired von Willebrand syndrome, primarily affects individuals over 65. Management requires a multidisciplinary approach, including medical therapy, endoscopic intervention, and valve replacement.
Yashika Gupta, Abdul Rehman Shahid Khan, Viraj Shetty, Yeshwini Murali Krishna, Ayisha Maqsood, Muhammad Husnain Ahmad, Masab Ali, Betsy Samuel, Ali Gohar, Abdul Waheed, Muhammad Bilal Afzal, Rehan Naseer Ahmad, Saqib Maqsood   +12 more
wiley   +1 more source

Cardiac stalling: Modelling energy balance in aortic stenosis and its role in syncope

The Journal of Physiology, EarlyView.
DeWayne Townsend
wiley   +1 more source

Cardiac Resynchronization Therapy: Reconsidering Its Essence as a Treatment for Electrical Dyssynchrony in Heart Failure

Journal of Arrhythmia, Volume 42, Issue 1, February 2026.
Flow of cardiac resynchronization therapy (CRT) in heart failure management. Heart failure (HF) patients with electrical dyssynchrony are first identified through screening. If electrical dyssynchrony contributes to HF deterioration, CRT is initiated to improve electrical synchrony.
Michio Ogano, Yu‐ki Iwasaki, Jun Tanabe, Wataru Shimizu, Kuniya Asai   +4 more
wiley   +1 more source

Suspected pro‐arrhythmic effects of flecainide and the limitations of in‐hospital short‐duration electrocardiography in detecting ventricular arrhythmia burden in a dog with dilated cardiomyopathy

Veterinary Record Case Reports, Volume 14, Issue 1, February 2026.
Abstract A 10‐year‐old, female, spayed Pitbull mix presented for evaluation of an arrhythmia. Echocardiography revealed enlargement of all cardiac chambers and decreased left ventricular systolic function. Electrocardiography demonstrated isolated, ventricular premature complexes.
Nathan Mitchell, Tamilselvam Gunasekaran, Robert Sanders, Joanne DeSana   +3 more
wiley   +1 more source

Maternal Myo‐Inositol Intake and Congenital Heart Defects in Offspring: A Population‐Based Case–Control Study

BJOG: An International Journal of Obstetrics &Gynaecology, Volume 133, Issue 3, Page 442-453, February 2026.
ABSTRACT Objective To investigate associations between maternal periconceptional (three months prior through the third pregnancy month) myo‐inositol intake and the odds of selected congenital heart defects in offspring. Design A population‐based case–control study using the National Birth Defects Prevention Study (NBDPS) database. Setting United States.
Ruiqi Cen, L. Joseph Su, Jun Ying, Mohammed S. Orloff, Elijah H. Bolin, Xiangyang Lou, Lynn M. Almli, Lorenzo D. Botto, Marilyn L. Browne, Richard H. Finnell, Mary M. Jenkins, Eirini Nestoridi, Andrew F. Olshan, Paul A. Romitti, Gary M. Shaw, Wendy N. Nembhard, the National Birth Defects Prevention Study   +16 more
wiley   +1 more source

Secukinumab in the Treatment of Moderate‐to‐Severe Hidradenitis Suppurativa: Pooled Pharmacokinetics and Safety Results From the SUNSHINE and SUNRISE Phase 3 Studies

International Journal of Dermatology, Volume 65, Issue 2, Page 289-298, February 2026.
ABSTRACT Background Secukinumab, a fully human, monoclonal antibody targeting interleukin‐17A, is approved for moderate‐to‐severe HS in adults. This study evaluated pharmacokinetics (PK), high‐sensitivity C‐reactive protein (hsCRP) changes, and safety of secukinumab over 52 weeks in SUNSHINE and SUNRISE Phase 3 trials.
Afsaneh Alavi, Ziad Reguiai, Gregor B. E. Jemec, Alice B. Gottlieb, Magdalena B. Wozniak, Lorenz Uhlmann, Heng Fan, Angela Llobet Martinez, Gerard Bruin, Nicolas Thomas, Ivette Alarcon, Bruno Bieth, Shoba Ravichandran, Alexa B. Kimball   +13 more
wiley   +1 more source